Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nerve conduction velocity is the speed at which an electrochemical signal (action potential) is propagated along a nerve fiber[1][5]. It is determined mainly by **axon diameter** and **myelination**, with myelinated fibers conducting much faster[1][2][9]. NCV is measured by stimulating a nerve and recording the time taken for the signal to reach a second point, allowing calculation of the signal speed[1][3][4][5]. Reduced NCV is associated with a wide range of peripheral nerve disorders, including demyelination and nerve injury, and serves as a key biomarker in the diagnosis and management of neuromuscular diseases[1][3][5][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nerve conduction velocity.